ALMAIDEA2017 - Evolution of health science and compliance with European and national law: experimentation, new technologies and pharmaceutical innovation

The evolution of health science is constantly going on both for the deepening of methodologies and biomedical knowledge, and for the continuous scientific and technological progress. However, often this progression does not go hand in hand with the necessary regulatory caution, with reference to the need for positive or negative protection of citizens, users, and the many and varied legal interests involved.

The widespread condition of normative asymmetry is contrasted by the need for harmonised regulation on the national, European and supranational territory, by virtue of the evident globalisation of the sector. The Project proposes the analysis of the main technological innovations in the health field, in terms of experimentation, new technologies and pharmaceutical innovation, with the aim of addressing the interrelationships between the individual components of the evolution of medical science in legal terms.

The research project intends to address the interrelationships between the individual components of the state of the art in function of its harmonious development. The project, in particular, aims to analyze the most significant aspects of the evolution of health science, identifying the main problems, through an in-depth study in legal terms.

Specific attention will be paid to the European scenario, the site of the main regulatory interventions on the subject, with obvious implications on the limits of medical science. Similarly, there will be an analysis of the constitutional profiles of the subject, involving the tension between scientific research and the interests of the human and animal person.

Research will have to proceed from the regulation of the main technological innovations in the field of health, in terms of experimentation, new technologies and pharmaceutical innovation.

The project aims to generate insights into the political, institutional, legal and scientific aspects of health evolution, as well as to analyze the impacts on institutions, on the supply of health and expectations of user protection. The effectiveness and legitimacy of the evolution of medical science in terms of processes, actors, tools and results will be critically evaluated, also from the point of view of European integration and the implications of medical practice on society. These activities will contribute to a better understanding of the challenges of medical science in a scenario of particular legal tension and perceived need for uniform protection on national, European and supranational territory, adopting a comprehensive and multidisciplinary approach.

The goal is to establish a grid of tools to reduce the uncertainty of the Community of reference and facilitate operations related to the scientific, pharmaceutical and health sector, both at national and supranational level.

Principal Investigator

Carlo Bottari

Full Professor

Torna su